These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 31201646)

  • 1. Interplay between thyroid cancer cells and macrophages: effects on IL-32 mediated cell death and thyroid cancer cell migration.
    Sloot YJE; Rabold K; Ulas T; De Graaf DM; Heinhuis B; Händler K; Schultze JL; Netea MG; Smit JWA; Joosten LAB; Netea-Maier RT
    Cell Oncol (Dordr); 2019 Oct; 42(5):691-703. PubMed ID: 31201646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alternatively spliced isoforms of IL-32 differentially influence cell death pathways in cancer cell lines.
    Heinhuis B; Plantinga TS; Semango G; Küsters B; Netea MG; Dinarello CA; Smit JWA; Netea-Maier RT; Joosten LAB
    Carcinogenesis; 2016 Feb; 37(2):197-205. PubMed ID: 26678222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammation-dependent secretion and splicing of IL-32{gamma} in rheumatoid arthritis.
    Heinhuis B; Koenders MI; van de Loo FA; Netea MG; van den Berg WB; Joosten LA
    Proc Natl Acad Sci U S A; 2011 Mar; 108(12):4962-7. PubMed ID: 21383200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A proinflammatory cytokine interleukin-32beta promotes the production of an anti-inflammatory cytokine interleukin-10.
    Kang JW; Choi SC; Cho MC; Kim HJ; Kim JH; Lim JS; Kim SH; Han JY; Yoon DY
    Immunology; 2009 Sep; 128(1 Suppl):e532-40. PubMed ID: 19740314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-32β stimulates migration of MDA-MB-231 and MCF-7cells via the VEGF-STAT3 signaling pathway.
    Park JS; Choi SY; Lee JH; Lee M; Nam ES; Jeong AL; Lee S; Han S; Lee MS; Lim JS; Yoon DY; Kwon Y; Yang Y
    Cell Oncol (Dordr); 2013 Dec; 36(6):493-503. PubMed ID: 24114327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A promoter polymorphism in human interleukin-32 modulates its expression and influences the risk and the outcome of epithelial cell-derived thyroid carcinoma.
    Plantinga TS; Costantini I; Heinhuis B; Huijbers A; Semango G; Kusters B; Netea MG; Hermus AR; Smit JW; Dinarello CA; Joosten LA; Netea-Maier RT
    Carcinogenesis; 2013 Jul; 34(7):1529-35. PubMed ID: 23486016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions between IL-32 and tumor necrosis factor alpha contribute to the exacerbation of immune-inflammatory diseases.
    Shoda H; Fujio K; Yamaguchi Y; Okamoto A; Sawada T; Kochi Y; Yamamoto K
    Arthritis Res Ther; 2006; 8(6):R166. PubMed ID: 17078892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-32beta propagates vascular inflammation and exacerbates sepsis in a mouse model.
    Kobayashi H; Huang J; Ye F; Shyr Y; Blackwell TS; Lin PC
    PLoS One; 2010 Mar; 5(3):e9458. PubMed ID: 20221440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The AMPK-activator AICAR in thyroid cancer: effects on CXCL8 secretion and on CXCL8-induced neoplastic cell migration.
    Awwad O; Coperchini F; Pignatti P; Denegri M; Massara S; Croce L; Di Buduo CA; Abbonante V; Balduini A; Chiovato L; Rotondi M
    J Endocrinol Invest; 2018 Nov; 41(11):1275-1282. PubMed ID: 29546654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumor activity of IL-32β through the activation of lymphocytes, and the inactivation of NF-κB and STAT3 signals.
    Yun HM; Oh JH; Shim JH; Ban JO; Park KR; Kim JH; Lee DH; Kang JW; Park YH; Yu D; Kim Y; Han SB; Yoon DY; Hong JT
    Cell Death Dis; 2013 May; 4(5):e640. PubMed ID: 23703385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-32δ interacts with IL-32β and inhibits IL-32β-mediated IL-10 production.
    Kang JW; Park YS; Lee DH; Kim MS; Bak Y; Park SH; Ham SY; Yang Y; Hong JT; Yoon DY
    FEBS Lett; 2013 Nov; 587(23):3776-81. PubMed ID: 24396867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Canagliflozin reduces thyroid cancer cells migration in vitro by inhibiting CXCL8 and CCL2: An additional anti-tumor effect of the drug.
    Coperchini F; Greco A; Croce L; Pignatti P; Muzza M; Petrosino E; Teliti M; Magri F; Rotondi M
    Biomed Pharmacother; 2024 Jan; 170():115974. PubMed ID: 38056240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumour necrosis factor alpha-driven IL-32 expression in rheumatoid arthritis synovial tissue amplifies an inflammatory cascade.
    Heinhuis B; Koenders MI; van Riel PL; van de Loo FA; Dinarello CA; Netea MG; van den Berg WB; Joosten LA
    Ann Rheum Dis; 2011 Apr; 70(4):660-7. PubMed ID: 21187297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diverse and divergent functions of IL-32β and IL-32γ isoforms in the regulation of malignant pleural mesothelioma cell growth and the production of VEGF-A and CXCL8.
    Numasaki M; Ito K; Takagi K; Nagashima K; Notsuda H; Ogino H; Ando R; Tomioka Y; Suzuki T; Okada Y; Nishioka Y; Unno M
    Cell Immunol; 2023 Jan; 383():104652. PubMed ID: 36516653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human IL-32 expression protects mice against a hypervirulent strain of Mycobacterium tuberculosis.
    Bai X; Shang S; Henao-Tamayo M; Basaraba RJ; Ovrutsky AR; Matsuda JL; Takeda K; Chan MM; Dakhama A; Kinney WH; Trostel J; Bai A; Honda JR; Achcar R; Hartney J; Joosten LA; Kim SH; Orme I; Dinarello CA; Ordway DJ; Chan ED
    Proc Natl Acad Sci U S A; 2015 Apr; 112(16):5111-6. PubMed ID: 25820174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination of IL-17 and TNFα induces a pro-inflammatory, pro-coagulant and pro-thrombotic phenotype in human endothelial cells.
    Hot A; Lenief V; Miossec P
    Ann Rheum Dis; 2012 May; 71(5):768-76. PubMed ID: 22258491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction with neutrophils promotes gastric cancer cell migration and invasion by inducing epithelial-mesenchymal transition.
    Zhang W; Gu J; Chen J; Zhang P; Ji R; Qian H; Xu W; Zhang X
    Oncol Rep; 2017 Nov; 38(5):2959-2966. PubMed ID: 28901479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Towards a role of interleukin-32 in atherosclerosis.
    Heinhuis B; Popa CD; van Tits BL; Kim SH; Zeeuwen PL; van den Berg WB; van der Meer JW; van der Vliet JA; Stalenhoef AF; Dinarello CA; Netea MG; Joosten LA
    Cytokine; 2013 Oct; 64(1):433-40. PubMed ID: 23727326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Caspase-3-independent apoptotic pathways contribute to interleukin-32γ-mediated control of Mycobacterium tuberculosis infection in THP-1 cells.
    Bai X; Kinney WH; Su WL; Bai A; Ovrutsky AR; Honda JR; Netea MG; Henao-Tamayo M; Ordway DJ; Dinarello CA; Chan ED
    BMC Microbiol; 2015 Feb; 15():39. PubMed ID: 25887904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypoxia-induced IL-32β increases glycolysis in breast cancer cells.
    Park JS; Lee S; Jeong AL; Han S; Ka HI; Lim JS; Lee MS; Yoon DY; Lee JH; Yang Y
    Cancer Lett; 2015 Jan; 356(2 Pt B):800-8. PubMed ID: 25449783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.